Systemic Bevacizumab Promising for Treatment-Resistant Recurrent Respiratory Papillomatosis March 5, 2018 Systemic bevacizumab appears to have significant promise and a low complication profile for the most treatment- resistant and aggressive forms of papillomatosis. Pages: 1 2 | Single Page